Skip to main content
Erschienen in: Reactions Weekly 1/2012

01.06.2012 | News item

TGA warns of candesartan risks in pregnancy

Erschienen in: Reactions Weekly | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Excerpt

In its latest Medicines Safety Update, the Australian Therapeutic Goods Administration (TGA) is reminding healthcare professionals that candesartan cilexetil and other angiotensin II receptor antagonists (and ACE-inhibitors) are contraindicated in pregnancy. …
Literatur
1.
Zurück zum Zitat TGA - Therapeutic Goods Administration.Candesartan, fetal malformations and use in pregnancy. Australian Prescriber 35: 98, No. 3, 1 Jun 2012. Available from: URL: http://www.tga.gov.au TGA - Therapeutic Goods Administration.Candesartan, fetal malformations and use in pregnancy. Australian Prescriber 35: 98, No. 3, 1 Jun 2012. Available from: URL: http://​www.​tga.​gov.​au
Metadaten
Titel
TGA warns of candesartan risks in pregnancy
Publikationsdatum
01.06.2012
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2012
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201214060-00003

Weitere Artikel der Ausgabe 1/2012

Reactions Weekly 1/2012 Zur Ausgabe

Case report

Aciclovir

Case report

Isotretinoin

Case report

Amiodarone

Case report

Tacrolimus